科学现状:心血管疾病与研究中症状的相关性——美国心脏协会科学声明
该美国心脏协会科学声明旨在阐述心血管疾病相关症状的科学现状与重要性,综述症状作为患者报告结局在起源、表现及不同诊断间的异同,涉及急性冠脉综合征、心力衰竭、瓣膜病、卒中、心律障碍及外周血管病,并描述症状测量方法及在临床实践中的应用。
要点
- 心血管疾病症状驱动医疗资源使用并显著影响生活质量。
- 症状对诊断、治疗反应评估及患者日常生活均具根本意义。
- 声明综述了多种心血管疾病症状的起源、表现及诊断间异同。
核心结论
- 症状是心血管疾病诊断、治疗反应评估及患者生活质量的核心要素。
研究设计与样本
- 美国心脏协会科学声明,综述症状作为患者报告结局的科学现状。
主要发现
- 症状驱动医疗资源使用并是生活质量的主要贡献因素。
- 综述了急性冠脉综合征、心力衰竭、瓣膜病、卒中、心律障碍及外周血管病的症状。
- 症状在起源、表现及不同诊断间存在相似或差异。
临床怎么用
- 临床中应重视症状作为患者报告结局的测量与应用。
- 症状评估不仅用于诊断,也用于评估治疗反应和患者日常生活影响。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Symptoms of cardiovascular disease drive health care use and are a major contributor to quality of life. Symptoms are of fundamental significance not only to the diagnosis of cardiovascular disease and appraisal of response to medical therapy but also directly to patients' daily lives. The primary purpose of this scientific statement is to present the state of the science and relevance of symptoms associated with cardiovascular disease. Symptoms as patient-reported outcomes are reviewed in terms of the genesis, manifestation, and similarities or differences between diagnoses. Specifically, symptoms associated with acute coronary syndrome, heart failure, valvular disorders, stroke, rhythm disorders, and peripheral vascular disease are reviewed. Secondary aims include (1) describing symptom measurement methods in research and application in clinical practice and (2) describing the importance of cardiovascular disease symptoms in terms of clinical events and other patient-reported outcomes as applicable.
引用
- Jurgens, Lee, Aycock, et al. State of the Science: The Relevance of Symptoms in Cardiovascular Disease and Research: A Scientific Statement From the American Heart Association. Circulation. 2022. PMID: 35979825. doi:10.1161/CIR.0000000000001089
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。